Teva Pharmaceutical Industries Retained Earnings (Accumulated Deficit) 2010-2024 | TEVA

  • Teva Pharmaceutical Industries retained earnings (accumulated deficit) for 2024 were $-15.173B, a 12.11% increase from 2023.
  • Teva Pharmaceutical Industries retained earnings (accumulated deficit) for 2023 were $-13.534B, a 4.31% increase from 2022.
  • Teva Pharmaceutical Industries retained earnings (accumulated deficit) for 2022 were $-12.975B, a 23.23% increase from 2021.

Quarterly Chart

Click on chart icon to view chart
Click on table icon to view table

Quarterly - YOY Change

Click on chart icon to view chart
Click on table icon to view table

Annual

Click on chart icon to view chart
Click on table icon to view table

Annual % Change

Click on chart icon to view chart
Click on table icon to view table
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$11.2B
BridgeBio Pharma (BBIO)$6.9B
Bausch Health Cos (BHC)$2.4B
Supernus Pharmaceuticals (SUPN)$1.9B
Amphastar Pharmaceuticals (AMPH)$1.5B
Personalis (PSNL)$412M
Taysha Gene Therapies (TSHA)$336M
Assembly Biosciences (ASMB)$81M
Sol-Gel Technologies (SLGL)$16M
Evoke Pharma (EVOK)$8M
Teligent (TLGT)$0M